Home Blog Page 996

Only 1 in 5 Professionals in Singapore and Malaysia Demonstrate AI-Ready Skills, New Epitome Data Reveals

By
Advertorial Desk
-

Aggregated multi-year assessments in Singapore and Malaysia highlight skills gaps as AI adoption accelerates


SINGAPORE – Media OutReach Newswire – 16 February 2026 – As artificial intelligence adoption accelerates across organisations, new data from workforce intelligence company Epitome Global signals that skills gaps may constrain the next phase of AI-driven productivity.

Based on aggregated skills assessments conducted across Singapore and Malaysia between 2023 and 2025, only around one in five professionals consistently demonstrate characteristics associated with AI-ready skills, including persistence, curiosity and reflective learning.

The findings are drawn from assessment data involving more than 200 participants across workforce development, employability and organisational programmes. While more than 70% of participants report advanced digital literacy, deeper skills gaps remain: approximately 56% rate themselves at a basic level in decision-making, and around 42% report only basic confidence in computational thinking, skills increasingly required to supervise AI tools, interpret outputs and integrate technology into workflows.

The data signals that as AI tools become more accessible, workforce readiness, rather than technology availability, may emerge as the primary constraint on performance in 2026.

“AI tools are scaling faster than workforce readiness,” said Kevin Chan, CEO of Epitome Global. “In the next phase of adoption, the differentiator will not be access to technology, but clarity around what people can actually do, how they make decisions, adapt and collaborate with AI-enabled systems.”

Five Workplace Trends to Watch in 2026

Based on these findings, Epitome identifies five workplace trends expected to shape organisations in 2026:

  1. Disengagement and skills decay as rising risks to productivity and performance: Only around 1 in 5 workers consistently display behaviours associated with AI ready talent, such as persistence, curiosity and reflective learning.
  2. Rapid AI adoption in the workplace in 2025 revealed gaps in AI integration: Despite strong uptake, 65% of organisations in Singapore remain focused on basic AI use cases, highlighting limits in scaling and embedding AI into workflows.
  3. Workers across Southeast Asia and India shifting from cost based outsourcing toward higher value technical roles: Professionals in markets such as the Philippines, Vietnam and India are expanding into engineering, product, IT and data science functions, competing more directly in global talent markets.
  4. Intensifying fire and hire cycles as organisations rebalance skills: In 2026, companies will continue to cut roles that no longer match future needs while hiring selectively for advanced technical and cross functional capabilities.
  5. Senior employability becoming more strategic in AI driven organisations: As Asia ages, employers are looking at how senior professionals can contribute as knowledge carriers, reviewers of AI assisted outputs and cross functional mentors.

As organisations move further into 2026, differences in outcomes are likely to be shaped less by the number of AI tools deployed and more by how clearly organisations understand, measure and develop workforce skills.

For the full market commentary, visit: https://epitome.global/
Hashtag: #epitomeglobal #technology #singapore #business #AI


The issuer is solely responsible for the content of this announcement.

Epitome Global

Founded in 2016 and headquartered in Singapore, Epitome Global is a workforce intelligence and skills analytics company that helps organisations understand, develop and deploy talent in an AI-enabled economy. Combining data analytics, artificial intelligence and sector-specific expertise, Epitome Global supports public and private sector organisations in workforce planning, skills assessment and targeted upskilling.

With approximately 1.3 million user profiles captured to date, Epitome Global leverages human capital analytics to power dashboards and workforce decision-making for enterprises and government agencies globally. Its platforms inform decisions around talent mobility, skills development and workforce transformation at scale.

Vinson & Elkins Secures Major Litigation Victory for Chinese Client

By
Advertorial Desk
-

WASHINGTON, Feb. 16, 2026 /PRNewswire/ — Vinson & Elkins today announced that it secured a significant victory for Wanhua Chemical Group Co., Ltd (“Wanhua China”) in a long-running antitrust class action alleging that chemical manufacturers conspired to fix prices and restrict the supply of methylene diphenyl diisocyanate (MDI) and toluene diisocyanate (TDI)—industrial chemicals widely used in in the production of  construction, automotive, furniture, and consumer goods.

In a comprehensive opinion released January 28, 2026, U.S. District Judge W. Scott Hardy of the Western District of Pennsylvania granted with prejudice Wanhua China’s motion to dismiss for lack of personal jurisdiction.

The opinion underscores that corporate separateness must be respected and that ordinary parent‑subsidiary relationships do not justify hauling a foreign corporation into a US court. The ruling represents one of the most significant recent decisions addressing when U.S. courts may—and may not—exercise jurisdiction over a Chinese parent company.

Read more here about the ruling’s impact on Chinese companies with a U.S. presence and operations.

This decision concludes nearly three years of jurisdictional discovery, during which Wanhua China produced thousands of documents—including materials requiring special approval under China’s Data Security Law and Personal Information Protection Law. The resulting record confirmed that Wanhua China maintains independent finances, operations, and decision‑making, and has no purposeful contacts with the U.S. market relevant to the litigation.

“We are pleased with the court’s decision and its thorough consideration of the jurisdictional record,” said Vinson & Elkins Partner Craig Seebald, counsel for Wanhua China.

Seebald was assisted by Vinson & Elkins Partners Adam Hudes and Nicole Castle and Counsel Brian Schnapp and Lincoln Wesley.

Vinson & Elkins has extensive experience representing Chinese and multinational companies in complex U.S. litigation, including antitrust MDLs, class actions, and jurisdictional disputes.

About Vinson & Elkins
For more than a century, Vinson & Elkins has provided outstanding client service across important industries that drive the global economy. Built on a strong culture of collaboration across 13 offices worldwide, V&E lawyers are committed to excellence, offering clients decades of legal experience in handling transactions, investments, projects and disputes across the globe. Learn more by visiting www.velaw.com or connect with us on LinkedIn.

UPGroup Asia and The MasterPlan LLP announce strategic partnership to deliver enterprise events across Singapore and Asia Pacific

By
Advertorial Desk
-

SINGAPORE, Feb. 16, 2026 /PRNewswire/ — UPGroup Asia and The MasterPlan LLP (“The MasterPlan”) today announced a strategic partnership that strengthens how both teams deliver enterprise events across Singapore and Asia Pacific.

Adam Piperdy (Founder & Chief Experience Officer, UPGroup Asia) and Jasmine Ho (Founder & Managing Partner, The MasterPlan) pictured with their leadership teams
Adam Piperdy (Founder & Chief Experience Officer, UPGroup Asia) and Jasmine Ho (Founder & Managing Partner, The MasterPlan) pictured with their leadership teams

The partnership combines UPGroup Asia’s integrated production capabilities, spanning creative direction, venue strategy, in-house technical production, and end-to-end delivery across the region, with The MasterPlan’s enterprise account leadership, programme design, and stakeholder management expertise. Together, both teams will support the delivery of complex, high-stakes event programmes through aligned planning, coordinated execution, and shared accountability.

Under the partnership, UPGroup Asia and The MasterPlan will collaborate on enterprise opportunities, aligning creative, technical, and operational expertise to deliver cohesive, consistently executed event experiences, supported by strong enterprise experience planning and deep production capability.

“This partnership reflects how we want to support our clients as their needs become more complex,” said Adam Piperdy, Founder and Chief Experience Officer of UPGroup Asia. “Working with The MasterPlan allows us to complement our production strengths with a strong end-to-end experience strategy, ensuring clarity and consistency from planning through execution.”

“Our clients want clarity, speed, and execution confidence. This partnership gives us deeper technical and production capability, supported by a strong regional delivery platform,” said Jasmine Ho, Founder, Managing Partner of The MasterPlan.

Over the coming months, UPGroup Asia and The MasterPlan will collaborate on industry initiatives in Singapore, showcasing combined approach to experience design, production, and event delivery.

UPGroup Asia and The MasterPlan LLP remain independent companies.

About UPGroup Asia

UPGroup Asia is an integrated event experience agency delivering event experiences in Singapore and Asia. Empowered by a team of creators, strategists, and experts who are deeply passionate about content, audience engagement, and event technology, UPGroup Asia delivers a complete suite of event solutions that allow event organisers to seamlessly execute award-winning event experiences. Producing hundreds of event experiences for thousands of audiences annually, UPGroup Asia is the trusted partner of both organisations and venue owners in the region.

About The MasterPlan LLP

At The MasterPlan, we specialize in the art of the B2B experience. We take the complexity of conferences, the wow moments at product launches, the prestige of CXO engagements, and the energy of brand activations, and distill them into a single, flawless execution. We don’t just plan events. We master the moments and guest experiences that move marketing campaigns forward with precision and connections.

Media contacts

Josiah Eufemio
Marketing and Communications Lead
josiah_eufemio@upgroup.asia 

Laiyee Wong
Senior Project Manager
laiyee@themasterplan.com.sg 

Community Med Care’s “Love & Share” CNY Blessing Campaign Gives the Gift of TCM Healing and Brings Hope to Children in Need

By
Advertorial Desk
-

HONG KONG, Feb. 16, 2026 /PRNewswire/ — This Lunar New Year, Community Med Care is turning seasonal blessings into lasting impact. The charity’s “Love & Share” CNY Blessing Campaign invites the public to support its flagship program, “Stand Up with Love: Angel Mission”, which provides free Traditional Chinese Medicine (TCM) consultations to children with autism, ADHD, congenital or acquired brain damage, and other special needs, offering them not just treatment, but a chance to thrive.


Acupuncture and TCM: A Path Forward for Nearly 1,300 Children

The Angel Mission provides TCM orthopaedic care to children and young people aged 0–30 living with congenital and acquired brain damage, autism, Down syndrome, rare diseases, and other conditions. Over the past seven years, the program has delivered more than 55,058 TCM consultations to nearly 1,300 children, walking alongside families on journeys that might otherwise feel impossible.

One such child is Tsz Ching, now nine years old. Diagnosed with developmental delay and hip dislocation, she once struggled to move freely and speak clearly. Since joining the Angel Mission in 2019, ongoing TCM treatment has helped her gain better control of her tongue and hands, and her ability to express herself has steadily improved. For her family, every small step forward, and every smile, is a gift.

A Donation. A TCM Treatment. A Future.

This festive season, Community Med Care is calling on the community to give the gift of healing. Every donation brings a child closer to recovery:

HK$200 – Provides 1 acupuncture session for 1 child

HK$300 – Provides 1 acupuncture session + 3 days of Chinese herbal medicine for 1 child

HK$600 – Provides 1 acupuncture session + 3 days of Chinese herbal medicine for 2 children

This New Year, make your blessing count. Support the “Love & Share” Campaign and help children like Tsz Ching take the next step toward a brighter future through TCM.

Donate now: https://communitymedcare.org/cny/

About Community Med Care:

Established in October 2018 by Professor Tinly Wong Tin-chee (Charity Tax Registration No.: 91/17034), Community Med Care’s “Angel Mission” provides free long-term rehabilitation services for children with autism, congenital and acquired brain injuries, and rare diseases. We also offer health training for parents of disabled children to help them better care for their children’s health needs.

Community Med Care’s vision is to provide rehabilitation services to those battling illness with limited resources, reigniting their hopes and dreams. From 2019 to December 2025, the “Angel Mission” has provided over 55,058 free treatments to more than 1,300 children and adolescents with brain diseases or cerebral palsy. We believe everyone deserves equal access to medical and rehabilitation services and will continue to expand our reach and impact to help more in need, restoring their health and rekindling their hopes and dreams for the future.

For more information about Community Med Care, please visit:

Website: https://communitymedcare.org/

Facebook: https://www.facebook.com/communitymedcareorg

Instagram: https://www.instagram.com/communitymedcareorg/

About Professor Tinly Wong Tin-chee:

A member of a prominent medical family in Hong Kong, Professor Wong has dedicated over 50 years to promoting the unique culture of traditional medicine in Hong Kong. Inspired by his father, he has a passion for research and has inherited his father’s wisdom and expertise, embodying the principles of “treating the root of illness” and “using pain as a point of treatment.” Professor Wong is a leading expert in pediatric brain diseases and established Community Med Care to provide rehabilitation services for children with brain conditions. He has been awarded the 2025 Hong Kong Humanity Award by the Hong Kong Red Cross in recognition of his long-standing dedication to supporting the disadvantaged and his selfless contribution to the practice of humanitarian spirit.

Media Inquiries:

Community Med Care
Phone: (852) 3997 3868
Email: info@communitymedcare.org

Media Contact:
info@sortieagency.com

CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to Advance into Phase II Clinical Trial

By
Advertorial Desk
-
  • CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase II clinical trial in patients with advanced solid tumors. This marks a significant milestone in the global development of this innovative immunotherapy.
  • The ongoing global multicenter Phase II trial is currently enrolling patients in Australia and China. The study design includes 15 cohorts evaluating both monotherapy and combination therapy regimens across 9 solid tumor indications, including but not limited to:
    • Non-small cell lung cancer (NSCLC)
    • Colorectal cancer (CRC)
    • Triple-negative breast cancer (TNBC)
    • Extensive-stage small cell lung cancer (ES-SCLC)‌
    • Platinum-resistant ovarian cancer (PROC)
  • Initial Phase I data for CS2009, previously presented at the 2025 European Society for Medical Oncology (ESMO) annual meeting, demonstrated a favorable safety profile with encouraging antitumor activities. Further clinical data from both the phase I and II is expected to be disclosed at the upcoming American Society of Clinical Oncology (ASCO) and ESMO congress later this year.

SUZHOU, China, Feb. 16, 2026 /PRNewswire/ — CStone Pharmaceuticals (“CStone,” HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced that the U.S. FDA has cleared the IND application to initiate a Phase II clinical trial of its core asset, CS2009, in patients with advanced solid tumors.

Dr. Jason Yang, CEO, President of R&D, and Executive Director at CStone, stated, “We are pleased to receive FDA clearance to proceed with the global Phase II clinical trial of CS2009. This milestone follows a productive interaction with the agency, during which they reviewed our comprehensive Phase I data—including safety and antitumor activity data collected during dose escalation and expansion—and provided alignment on key elements of the Phase II study design, including dose optimization and expansion strategies. We are now actively advancing CS2009 clinical program globally and look forward to sharing further updates as the study progresses.”

About CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)

CS2009, an innovative trispecific antibody designed and developed by CStone, with the potential to be first- or best-in-class. It combines three clinically validated targets—PD-1, VEGFA, and CTLA-4—and exerts multidimensional anti-tumor effects through synergistic actions. Specifically, anti-PD-1 activity reverses T cell exhaustion, anti-CTLA-4 activity promotes T cell activation and proliferation, while anti-VEGFA activity blocks tumor angiogenesis and improves the tumor micro-environment (TME). In the TME, anti-PD-1 and anti-CTLA-4 activities are significantly enhanced by crosslinking with VEGFA. Meanwhile, CS2009 preferentially blocks PD-1 and CTLA-4 on double-positive tumor-infiltrating T cells while minimizing interference with CTLA-4 regulation in peripheral T cells.

The ongoing global, multicenter Phase II clinical trial of CS2009 features a multi-cohort, parallel expansion design to evaluate the efficacy, safety, tolerability, and pharmacokinetics/pharmacodynamics (PK/PD) of CS2009 as monotherapy and combination regimens. The study comprises 15 monotherapy and combination therapy cohorts across 9 solid tumor indications, including NSCLC, CRC, TNBC, ES-SCLC, PROC, cervical cancer (CC), hepatocellular carcinoma (HCC), gastric or gastroesophageal junction cancer (GC/GEJC), and esophageal squamous cell carcinoma (ESCC). The trial is actively enrolling patients in Australia and China and has received IND clearance in the U.S.

About CStone

CStone (HKEX: 2616), established in late 2015, is an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas. Dedicated to addressing patients’ unmet medical needs in China and globally, the Company has made significant strides since its inception. To date, the Company has successfully launched 4 innovative drugs and secured approvals for 20 new drug applications covering 9 indications. The company’s pipeline is balanced by 16 promising candidates, featuring potentially first-in-class or best-in-class antibody-drug conjugates (ADCs), multispecific antibodies, immunotherapies and precision medicines. CStone also prides itself on a management team with comprehensive experiences and capabilities that span the entire drug development spectrum, from preclinical and translational research to clinical development, drug manufacturing, business development, and commercialization. For more information about CStone, please visit: www.cstonepharma.com. 

Forward-looking statements

The forward-looking statements made in this article only relate to events or information as of the date when the statements are made in this article. Except as required by law, we undertake no obligation to update or publicly revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. All statements in this article are made on the date of publication of this article and may change due to future developments.

Disclaimer: only for communication and scientific use by medical and health professionals, it is not intended for promotional purposes.

MDEC and MDV Join Forces to Accelerate WAHDAH’s Mission in Shaping Malaysia’s Digital Mobility and Travel Tech Ecosystem

By
Advertorial Desk
-

KUALA LUMPUR, Malaysia, Feb. 16, 2026 /PRNewswire/ — Malaysia’s digital transformation continues to gain momentum as the Malaysia Digital Economy Corporation (MDEC) strengthens its efforts to empower local innovators through strategic collaborations and alternative funding avenues.

WAHDAH exchanging MoU documents with Haup Car at MDEC DEX Connex 2025, reinforcing regional mobility collaboration between Malaysia and Thailand.
WAHDAH exchanging MoU documents with Haup Car at MDEC DEX Connex 2025, reinforcing regional mobility collaboration between Malaysia and Thailand.

One of the latest success stories emerging from Malaysia’s digital ecosystem is WAHDAH Technologies Sdn. Bhd., a homegrown mobility and travel-tech company that connects mobility, automotive and tourism sectors through an integrated digital platform.

MDEC has been instrumental in WAHDAH’s journey, facilitating ecosystem visibility, providing market access and enabling participation in strategic digital adoption programmes These initiatives have helped strengthen WAHDAH’s technological capabilities, accelerate its business model evolution and support its regional growth trajectory.

This announcement comes at a pivotal time as Malaysia advances its digitalisation agenda under Malaysia Digital (MD) and RMK12, particularly within priority areas such as digital mobility, travel-tech and platform-based innovation. The collaboration between MDEC, Malaysia Debt Ventures Berhad (MDV) and WAHDAH also reinforces aspirations under AI Nation 2030, supporting the development of data-driven mobility solutions, fleet intelligence and cross-border digital trade.

“MDEC remains committed to empowering high-potential Malaysian innovators such as WAHDAH to accelerate digital adoption and regional expansion,” said Anuar Fariz Fadzil, Chief Executive Officer of MDEC “This collaboration with MDV reinforces key national priorities under Malaysia Digital (MD), RMK12 and AI Nation 2030 by supporting data-driven mobility platforms, strengthening digital-first business models and opening pathways for Malaysian tech companies to grow across Southeast Asia. WAHDAH’s progress reflects the strength of Malaysia’s ecosystem in nurturing future regional digital champions.”

Recognizing WAHDAH’s potential to lead innovation in Malaysia’s digital mobility landscape, Malaysia Debt Ventures Berhad (MDV), a subsidiary of the Minister of Finance (Incorporated) [MOF Inc] and an agency under the Ministry of Science, Technology and Innovation (MOSTI), has extended a RM2.5 million financing facility to support and accelerate WAHDAH’s mission. MDV’s financing assistance model supports WAHDAH’s working capital needs to sustain business growth and strengthen operational capacity.

Together, MDEC and MDV have carved a clear growth pathway for WAHDAH, supporting its scale up and positioning the company towards a cumulative projected revenue growth of RM40 million

WAHDAH is a mobility and travel tech company that connects the worlds of mobility, automotive, and tourism by empowering how people move, own, and experience travel across Malaysia, Indonesia, and Singapore through both physical hubs and digital platforms.

Operating across all key economic regions of Malaysia, WAHDAH is supported by nearly 100 employees with physical touchpoints nationwide, including regional hubs and satellite offices in Langkawi, Kuala Lumpur, Penang, Ipoh, Melaka, Johor Bahru, Jakarta and Singapore. These hubs serve as strategic bases that provide comprehensive end-to-end mobility and customer support solutions.

By leveraging digital platforms and data-driven systems, WAHDAH has redefined the mobility experience across Southeast Asia. Its ecosystem includes Driveo, a fleet management platform that digitizes the full cycle of vehicle ownership from Purchase, Protect, Maintain, Earn, and Sell and Trevabook, a travel-tech brand that delivers authentic, locality-driven travel experiences in line with Malaysia’s vision of sustainable and inclusive digital growth.

“WAHDAH has demonstrated strong potential and capability to scale beyond Malaysian shores and MDV is confident that with the right funding support, it will continue to grow and deliver impact across the wider digital ecosystem,” said Rizal Fauzi, Chief Executive Officer (CEO) of MDV.

This partnership underscores MDV’s continued commitment to empowering technology-based companies and start-ups through innovative and specialized solutions that drive sustainable growth and strengthen Malaysia’s position as a regional innovation hub.”

Following WAHDAH’s strong performance, WAHDAH is continuously seeking strategic opportunities that can further accelerate its growth and technological advancement.

The alignment between MDEC’s digital empowerment programs and MDV’s financing initiatives, and the success of local innovators like WAHDAH reflects Malaysia’s evolving strategy, one that merges institutional support, innovation and entrepreneurship to strengthen the digital economy.

Through continued collaboration, Malaysia reaffirms its commitment to building a dynamic, sustainable, and inclusive innovation ecosystem, one where public and private sectors move in tandem toward a shared vision of a future-ready digital nation.

SMU MBA Rises in FT Global Rankings, Excelling in ESG, Salary and Value-for-Money

By
Advertorial Desk
-

Programme advances across key Financial Times metrics, including ESG and Net Zero teaching, value-for-money and career outcomes, reinforcing its global reputation

SINGAPORE, Feb. 16, 2026 /PRNewswire/ — Singapore Management University’s (SMU) Master of Business Administration (MBA) programme has advanced 15 spots to rank again among the best business schools globally in the Financial Times (FT) 2026 Top 100 Global MBAs. Significantly, SMU’s MBA programme excelled in key metrics such as sustainability-focused teaching, world-leading research and career progression.

FT’s newly released annual ranking evaluated 100 MBA programmes worldwide against a rigorous set of criteria. Drawing on comprehensive surveys of both business schools and their graduates, the closely watched rankings assessed programme design alongside institutional strengths.

“In a period of heightened global uncertainty, we have embedded ESG and sustainability across the MBA curriculum in response to pressing business expectations, ensuring our graduates are equipped to lead responsibly,” said Professor Bert De Reyck, Dean of SMU’s Lee Kong Chian School of Business. “Our performance in the Financial Times rankings reflects our focus on preparing leaders who can navigate complexity, drive organisational performance and contribute meaningfully to business and society.” 

Significantly, the SMU MBA achieved a major leap of 57 places to place 18th globally in the FT’s ‘ESG and net zero teaching’ ranking, reflecting the programme’s strong integration of ESG-focused content and commitment to long-term value creation. The SMU MBA’s international faculty and student diversity served to enable multi-faceted perspectives that enriched ESG discussions, further reinforcing the programme’s global orientation. This recognition affirmed SMU’s commitment to equipping graduates with practical skills to meet the growing demand across industries worldwide, for sustainability and responsible investing expertise.

In terms of FT’s metric of ‘research ranking’, the SMU MBA jumped four spots to notch 2nd place in Singapore and 33rd place globally. This underscored the programme’s strong research foundations and its integration of research-led insights into curriculum, in alignment with the University’s SMU2030 vision of creating meaningful impact and transforming lives through education, research and partnerships.

Since its inception in 2009, the SMU MBA has consistently delivered solid value to its graduates. Of note, the programme ranked amidst the top tier at 23rd spot globally in the FT’s ‘value-for-money’ indicator, which measured the average alumni salary three years after graduation relative to the total cost of the MBA. The programme jumped 18 spots in FT’s metric of ‘career progress’ (to 56th), demonstrating advancement amongst alumni three years after graduation. SMU MBA alumni reported a weighted salary of US$155,830 which underscored the programme’s strong post-MBA earning trajectory.

The programme’s strong showing in the latest FT rankings attested to the SMU MBA’s effectiveness in preparing graduates to navigate global and economic change. As geopolitical tensions, trade uncertainties and technology reshape industries and career pathways, the programme jumped 15 spots to rank within the top tier MBAs (57th worldwide, 13th in Asia) and to deliver significant and measurable outcomes for its graduates.

Commitment to lifelong learning

The University regularly enhances curricula to reflect shifts in business and society, ensuring that graduates are prepared for the realities of a rapidly changing global economy. Most recently, SMU launched a new Master of Science in Business AI, aimed at developing business leaders fluent in AI and grounded in cross-functional business knowledge and strategy.

As part of its commitment to lifelong learning, SMU supports professionals and alumni seeking to upskill or pivot at different career stages through its postgraduate offerings, including the MBA, with more than 100 scholarships available.

About the SMU MBA

Started in 2009, the SMU MBA is a well-recognised programme characterised by close engagement with industry. Students learn through real-world case studies from Asia, alongside best practices from global companies. Helmed by an internationally diverse faculty who deliver interactive and seminar-style classes, the SMU MBA provides valuable opportunities to build networks and to engage with outstanding leaders from the business community.

The MBA programme at SMU stands out for its flexibility, allowing students to tailor their educational journey to fit their unique schedules. Each year, there are dual intakes offered for both the part-time and full-time programmes. With a thoughtfully designed structure, graduates can achieve their MBA in as little as 10, 12 or 15 months, ensuring flexibility amidst hectic professional schedules. Learners have the option of tailoring their learning journey by selecting the number of elective modules they take each term, allowing flexibility in their completion timeline.

SMU LKCSB was one of the youngest business schools in the world and the only Singaporean business school in 2018 to achieve ‘Triple Crown’ accreditation. This distinction of being triple accredited by the Association to Advance Collegiate Schools of Business (AACSB), AMBA and European Quality Improvement System (EQUIS), is held by a very select group of business schools around the world.

Visit FT Global MBA Rankings for the full results.

 

Lee Kum Kee Sauce Serves as Platinum Sponsor of the 2026 Chinese New Year Festival & Market Day

By
Advertorial Desk
-

Bringing Festive Flavours and Delicious Moments to the Community


AUCKLAND, NEW ZEALAND – Media OutReach Newswire – 16 February 2026 – Lee Kum Kee Sauce (“Lee Kum Kee”), the global leader of Asian sauces and condiments, marked a successful debut as the Platinum Sponsor of the 2026 Chinese New Year Festival & Market Day in Auckland. Co-hosted by the Auckland Chinese Community Centre (ACCC) and Channel 33, this festival was held on 14 February 2026, in celebration of the upcoming Year of the Horse, bringing together families, community groups, and cultural performers.

The Lee Kum Kee booth draws strong crowds at the 2026 Auckland Chinese New Year Festival & Market Day.
The Lee Kum Kee booth draws strong crowds at the 2026 Auckland Chinese New Year Festival & Market Day.

Set against the backdrop of the Auckland Showgrounds, the festival featured over 200 specialist stalls offering traditional Chinese hot delicacies, festive foodstuffs and traditional arts and crafts, attracting over 20,000 visitors. The extensive entertainment programme included lion dances, traditional Chinese songs and performances that brought the spirit of the celebrations to life.

Lee Kum Kee set up a captivating booth experience for festivalgoers of all ages, allowing them to explore an extensive range of sauces through delectable tastings, exclusive promotional sales, and the exciting “Chopstick Lucky Dip” prize-giving game, which drew enthusiastic participation throughout the event.

A visitor tries his luck by drawing chopsticks from the luck dip game.
A visitor tries his luck by drawing chopsticks from the luck dip game.

Gary Hui (left), Business Development Director – Oceania of Lee Kum Kee Sauce, presents a cheque to the ACCC as a Platinum Sponsor of the event.
Gary Hui (left), Business Development Director – Oceania of Lee Kum Kee Sauce, presents a cheque to the ACCC as a Platinum Sponsor of the event.

In serving the local community, Lee Kum Kee aims to bring traditional festive moments to life. Gary Hui, Business Development Director – Oceania of Lee Kum Kee Sauce, remarked, “Spring Festival represents family, togetherness, and the joy of sharing meals. We are proud to support an event that reflects these values. Whether you are discovering new tastes or enjoying familiar favourites, we hope this festival brings joy and connection to all.”

(Fourth from left) Vincent Wong, President - APAC of Lee Kum Kee Sauce, pictured with the New Zealand market team at the booth.
(Fourth from left) Vincent Wong, President – APAC of Lee Kum Kee Sauce, pictured with the New Zealand market team at the booth.

A trusted household name for generations, Lee Kum Kee is renowned for its authentic Asian sauces that inspire home cooking and festive dining. Through on-going community partnerships and cultural celebrations, Lee Kum Kee remains committed to supporting local communities while promoting Chinese culinary culture worldwide through the joy of food.Hashtag: #LeeKumKee #LKK

The issuer is solely responsible for the content of this announcement.

About Lee Kum Kee

Lee Kum Kee is the global gateway to Asian culinary culture, dedicated to promoting Chinese culinary culture worldwide. Since 1888, it has brought people together over joyful reunions, shared traditions, and memorable meals. Beloved by consumers and chefs alike, Lee Kum Kee’s range of more than 300 sauces and condiments sparks creativity in kitchens everywhere, inspiring professional and home chefs to experiment, create, and delight. Headquartered in Hong Kong, China and serving over 100 countries and regions, Lee Kum Kee’s rich heritage, unwavering commitment to quality, sustainable practices, and “Constant Entrepreneurship” combine to enable superior experiences through Asian cuisine for people worldwide. For more information, please visit www.LKK.com.

1...995996997...6,462Page 996 of 6,462